Terms: = Germ cell tumor AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
38 results:
1. Design, synthesis and biological evaluation of nrf2 modulators for the treatment of glioblastoma multiforme.
Yang H; Song P; Li B; Li S; Yang J
Bioorg Med Chem; 2024 Apr; 103():117684. PubMed ID: 38493731
[TBL] [Abstract] [Full Text] [Related]
2. Endothelial Mitochondria Transfer to Melanoma Induces M2-Type Macrophage Polarization and Promotes tumor Growth by the nrf2/HO-1-Mediated Pathway.
Kuo FC; Tsai HY; Cheng BL; Tsai KJ; Chen PC; Huang YB; Liu CJ; Wu DC; Wu MC; Huang B; Lin MW
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339136
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of Ferroptosis Regulators with Regard to PD-L1 and Immune Infiltration in Low-Grade Glioma.
Luan Y; Chen Y; Wang Y; Shu M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629061
[TBL] [Abstract] [Full Text] [Related]
5. TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1.
Wei J; Wang L; Zhang Y; Sun T; Zhang C; Hu Z; Zhou L; Liu X; Wan J; Ma L
Oncogene; 2023 Jun; 42(26):2103-2112. PubMed ID: 37188737
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a copper metabolism-related gene signature for predicting prognosis and immune response in glioma.
Li L; Leng W; Chen J; Li S; Lei B; Zhang H; Zhao H
Cancer Med; 2023 Apr; 12(8):10123-10137. PubMed ID: 36856182
[TBL] [Abstract] [Full Text] [Related]
7. Survival Mechanisms of Metastatic Melanoma cells: The Link between Glucocorticoids and the nrf2-Dependent Antioxidant Defense System.
Obrador E; Salvador-Palmer R; López-Blanch R; Oriol-Caballo M; Moreno-Murciano P; Estrela JM
Cells; 2023 Jan; 12(3):. PubMed ID: 36766760
[TBL] [Abstract] [Full Text] [Related]
8. The dual role of nrf2 in melanoma: a systematic review.
Malakoutikhah Z; Mohajeri Z; Dana N; Haghjooy Javanmard S
BMC Mol Cell Biol; 2023 Feb; 24(1):5. PubMed ID: 36747120
[TBL] [Abstract] [Full Text] [Related]
9. PRMT1 driven PTX3 regulates ferritinophagy in glioma.
Lathoria K; Gowda P; Umdor SB; Patrick S; Suri V; Sen E
Autophagy; 2023 Jul; 19(7):1997-2014. PubMed ID: 36647288
[TBL] [Abstract] [Full Text] [Related]
10. Ferroptosis-related nfe2l2 and NOX4 Genes are Potential Risk Prognostic Biomarkers and Correlated with Immunogenic Features in Glioma.
Lin L; Li X; Zhu S; Long Q; Hu Y; Zhang L; Liu Z; Li B; Li X
Cell Biochem Biophys; 2023 Mar; 81(1):7-17. PubMed ID: 36627482
[TBL] [Abstract] [Full Text] [Related]
11. Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma.
Watanabe E; Yokoi A; Yoshida K; Sugiyama M; Kitagawa M; Nishino K; Yamamoto E; Niimi K; Yamamoto Y; Kajiyama H
Cancer Med; 2023 Feb; 12(4):4543-4556. PubMed ID: 36106577
[TBL] [Abstract] [Full Text] [Related]
12. Machine learning for the micropeptide encoded by LINC02381 regulates ferroptosis through the glucose transporter SLC2A10 in glioblastoma.
Jiang L; Yang J; Xu Q; Lv K; Cao Y
BMC Cancer; 2022 Aug; 22(1):882. PubMed ID: 35962317
[TBL] [Abstract] [Full Text] [Related]
13. High levels of nrf2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation.
de Souza I; Monteiro LKS; Guedes CB; Silva MM; Andrade-Tomaz M; Contieri B; Latancia MT; Mendes D; Porchia BFMM; Lazarini M; Gomes LR; Rocha CRR
Cell Death Dis; 2022 Jul; 13(7):591. PubMed ID: 35803910
[TBL] [Abstract] [Full Text] [Related]
14. GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair.
Xu H; Jin J; Chen Y; Wu G; Zhu H; Wang Q; Wang J; Li S; Grigore FN; Ma J; Chen CC; Lan Q; Li M
Oncogene; 2022 Jul; 41(31):3876-3885. PubMed ID: 35780181
[TBL] [Abstract] [Full Text] [Related]
15. Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/nrf2 and CBS-regulated ferroptosis.
Zheng XJ; Chen WL; Yi J; Li W; Liu JY; Fu WQ; Ren LW; Li S; Ge BB; Yang YH; Zhang YZ; Yang H; Du GH; Wang Y; Wang JH
Acta Pharmacol Sin; 2022 Nov; 43(11):2977-2992. PubMed ID: 35581292
[TBL] [Abstract] [Full Text] [Related]
16. HACE1-mediated nrf2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells.
Da C; Pu J; Liu Z; Wei J; Qu Y; Wu Y; Shi B; Yang J; He N; Hou P
Signal Transduct Target Ther; 2021 Nov; 6(1):399. PubMed ID: 34815381
[TBL] [Abstract] [Full Text] [Related]
17. nrf2 Enables EGFR Signaling in Melanoma cells.
Kreß JKC; Jessen C; Marquardt A; Hufnagel A; Meierjohann S
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33916908
[TBL] [Abstract] [Full Text] [Related]
18. Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study.
Tosoni A; Gatto L; Franceschi E; Di Nunno V; Lodi R; Mura A; Di Battista M; Bartolini S; Brandes AA
Eur J Cancer; 2021 Mar; 145():171-178. PubMed ID: 33486440
[TBL] [Abstract] [Full Text] [Related]
19. Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries.
Rocha CRR; Reily Rocha A; Molina Silva M; Rodrigues Gomes L; Teatin Latancia M; Andrade Tomaz M; de Souza I; Karolynne Seregni Monteiro L; Menck CFM
Cells; 2020 Dec; 9(12):. PubMed ID: 33271924
[TBL] [Abstract] [Full Text] [Related]
20. Ferroptosis: a new unexpected chance to treat metastatic melanoma?
Gagliardi M; Saverio V; Monzani R; Ferrari E; Piacentini M; Corazzari M
Cell Cycle; 2020 Oct; 19(19):2411-2425. PubMed ID: 32816618
[TBL] [Abstract] [Full Text] [Related]
[Next]
